Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals

SYDNEY, May 11, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Shaemus Gleason as Executive Vice President U.S. Operations as the company expands its presence, clinical trials, and operations in the U.S.

Shaemus joins...

Read more: Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals

More Articles …

  1. Enapter preparing AEM Multicore for 2022 launch
  2. Atlantic Nickel reports continued first quartile cost performance in Q1 2021; upgrades and adds another 20% to the declared Underground Mineral Resource
  3. SME property development lending boost with launch of non-bank alternative CrowdProperty
  4. Objective Acuity announces successful pilot study in children with CLN2 Batten disease
  5. Nayax Announces the Pricing of its Initial Public Offering
  6. Bionomics BNC210 Expansion into Social Anxiety Disorder
  7. Free online anti-harassment training launched by The College of Law and International Bar Association to make cultural change in the #MeToo era
  8. Aaseya Receives the Client Innovation Award for Social Responsibility from Pega
  9. UserTesting Research Finds Australians Express Caution Regarding Travel Bubble, and For Good Reason
  10. Vakrangee Enters The Online Space With The Launch Of Digital Services